Glen Harbor Capital Management’s Core Laboratories CLB Stock Holding History

Glen Harbor Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$319K	Buy	6,842 +1,298	+23%	+$60.3K	0.01%	867
2019 Q2	$290K	Hold	5,544	–	–	0.01%	896
2019 Q1	$382K	Hold	5,544	–	–	0.01%	773
2018 Q4	$331K	Hold	5,544	–	–	0.01%	764
2018 Q3	$642K	Buy	5,544 +748	+16%	+$84.4K	0.01%	613
2018 Q2	$605K	Sell	4,796 -902	-16%	-$110K	0.01%	586
2018 Q1	$617K	Sell	5,698 -2,090	-27%	-$231K	0.01%	564
2017 Q4	$853K	Sell	7,788 -2,486	-24%	-$248K	0.02%	473
2017 Q3	$1.01M	Buy	10,274 +3,344	+48%	+$324K	0.02%	408
2017 Q2	$702K	Sell	6,930 -2,332	-25%	-$251K	0.02%	496
2017 Q1	$1.07M	Hold	9,262	–	–	0.03%	394
2016 Q4	$1.11M	Buy	+9,262	New	+$1.03M	0.03%	357

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Glen Harbor Capital Management's CLB Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Core Laboratories (CLB) stake by 23% in Q3 2019, buying an estimated $60.3K and bringing the position to 6,842 shares worth $319K. The position accounts for 0.01% of the portfolio, ranked #867.

Glen Harbor Capital Management first reported a position in CLB in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.11M in Q4 2016. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Glen Harbor Capital Management held 6,842 shares of Core Laboratories worth $319K as of Q3 2019.
Glen Harbor Capital Management bought 1,298 Core Laboratories shares in Q3 2019, an estimated $60.3K.
Core Laboratories made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #867 holding.
Glen Harbor Capital Management first reported a position in Core Laboratories in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's Core Laboratories position peaked at $1.11M in Q4 2016.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.